- Motley Fool•11 days ago
Do Adamas Pharmaceuticals and Amicus Therapeutics have the potential to power your portfolio higher?
- MarketWatch•24 days ago
Harry Boxer highlights bluebird bio, Amicus Therapeutics, Kite Pharma and NeuroDerm.
- Insider Monkey•25 days ago
President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S. Food and Drug Administration as burdensome and slow. Trump used the example of the now 20-year-old Megan Crowley who was diagnosed with a rare disease known as Pompe Disease at the age of […]
AM6.F : Summary for AMICUS THERAPEUTICS INC. - Yahoo Finance
Amicus Therapeutics, Inc. (AM6.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 8:04AM CEST. Market open.
|Bid||6.72 x 50000|
|Ask||6.99 x 50000|
|Day's Range||6.47 - 6.47|
|52 Week Range||4.25 - 8.82|
|PE Ratio (TTM)||-4.35|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|